In conclusion, our study showed that higher PSMA uptake, best represented as high tumour-to-background uptake in the hottest lesion, can be of the most significant prognostic value in PCa patients receiving [177Lu]Lu-PSMA-I&T therapy. This evidence concerns the gene FOLH1 and posterior cortical atrophy.